GAL and allergic disease: Cetuximab is a chimeric monoclonal antibody that contains alpha-gal and can lead to allergic reactions in individuals with alpha-gal syndrome.<h4>Methods</h4>A 66-year-old with metastatic squamous cell carcinoma of the right tonsil with involvement of the lung and liver was planned to receive palliative therapy with cetuximab.